Abell Foundation invests in eye scanner firm

February 25, 2016

The Abell Foundation announced Tuesday that it has invested $250,000 in Vasoptic Medical Inc., a Baltimore-based firm that’s developing a portable retinal imager to make it easier to monitor diabetes and diseases of the eye.


Vasoptic moved into Baltimore from Columbia in August after a $250,000 investment last year from Abell, which makes targeted venture-capital investments in firms to foster technology and research in the city. The foundation’s ultimate goal is to create jobs in Baltimore.


"Expanding our investment in Vasoptic Medical Inc. is a win-win for Baltimore," the Abell Foundation board said in a statement. "Vasoptic is growing Baltimore's innovative tech industry and is poised to improve access to affordable healthcare for low-income populations."


For full story click here.

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 15, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 25, 2017

Early Detection: New Device Measures Risk of Blindness from Diabetes

October 7, 2016

Please reload

© 2020 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230